.Merck defeats incomes desires, rears purchases expectation on sturdy requirement for leading drugs like Keytruda CNBCMerck & Co. (MRK US) Defeats Income Estimates as Keytruda Sales Rise BloombergMerck Inventory: Pharma Giant Posts Tough Results, But Expectation Drops Short Financier's Business DailyMerck Announces Second-Quarter 2024 Financial End results Yahoo FinanceMerck defeats revenue as well as sales expectations surrounded by Keytruda advantage, but gives mixed full-year expectation MarketWatch.